RxDoctor Payments Data

Jerrold Ecklind, DO

Family Medicine · Wildwood, FLNPI 1851390322

Payments from drug & device makers

$1,401in general payments, 2019–2025

Across 78 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$220
  • GSK$167
  • Johnson & Johnson$140
  • Amgen$123
  • Pfizer$118
  • Boehringer Ingelheim$114
  • plus $519 from 15 others

What the payments were for

  • Food & beverage$1,401100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,401 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$203,926
Medicare patients
462
Services billed
2,408

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter131$195,963
EliquisApixaban142$166,750
XareltoRivaroxaban49$65,003
OzempicSemaglutide48$62,792
Combivent RespimatIpratropium/Albuterol Sulfate46$44,780
FarxigaDapagliflozin Propanediol34$44,211
JanuviaSitagliptin Phosphate31$40,577
JardianceEmpagliflozin36$38,881
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen703$27,752
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog18$26,704
Breztri AerosphereBudesonide/Glycopyr/Formoterol23$25,202
MyrbetriqMirabegron37$24,367
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog39$24,235
TrulicityDulaglutide20$21,879
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen721$21,540

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$167$213,897151 claims
PfizerEliquis$118$166,750142 claims
Boehringer IngelheimCombivent Respimat, Jardiance, Spiriva Respimat$114$99,029101 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$220$88,564104 claims
Johnson & JohnsonXarelto$140$65,00349 claims
Novo NordiskOzempic$12$62,79248 claims
Astellas Pharma US IncMyrbetriq$14$24,36737 claims
Lilly USA, LLCTrulicity$69$21,87920 claims
NovartisEntresto$75$15,15012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Wildwood

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →